Effects of Chitosan Coating for Liposomes as an Oral Carrier

  • Lee, Chang-Moon (Department of Nuclear Medicine, Chonbuk National University Medical School and Hospital) ;
  • Kim, Dong-Woon (Department of Clinical Pathology, Gwangyang Health College) ;
  • Lee, Ki-Young (Faculty of Applied Chemical Engineering, Chonnam National University)
  • 투고 : 2011.09.09
  • 심사 : 2011.09.28
  • 발행 : 2011.09.30

초록

The chitosan-coated liposomes (chitosomes) were designed to improve the stability in the gastrointestinal (GI) tract and to enhance the efficacy for oral drug delivery of liposomes. The phosphatic acid (PA)-incorporated anionic liposomes were surface-coated with water soluble chitosan (WSC) by electro-ionic interaction. The shape of the chitosomes observed by transmission electron microscopy (TEM) was spherical in all the formulations and the coating layer by WSC could be founded through TEM images. The mean size and the zeta potential values of the chitosomes increased significantly with depending on the content of WSC added for coating the liposomes. The stability of the chitosomes in the GI tract was confirmed through the change of relative turbidity of the liposomal suspension. The plain liposomes (plasomes) suspension without adding WSC clearly showed the change of relatively turbidity in simulated gastric fluid (SGF), while the change degree of turbidity of the chitosomes in the SGF decreased as increasing of WSC content added for coating liposome. In the 5-CF release study from the plasomes and chitosomes, the plasomes released >90% of the initial 5-CF content at 4 h of release measurement. In contrast, the chitosomes released below 40% of initial content of 5-CF. In conclusion, these results indicate that the chitosomes can be used as a potential carrier for effective oral drug delivery.

키워드

참고문헌

  1. Barea MJ, Jenkins MJ, Gaber MH, Bridson RH. Evaluation of liposomes coated with a pH responsive polymer. Int J Pharm. 2010. 402: 89-94. https://doi.org/10.1016/j.ijpharm.2010.09.028
  2. Cao J, Sun J, Wang X, Li X, Deng Y. N-trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev Ind Pharm. 2009. 35: 1339-1347. https://doi.org/10.3109/03639040902902427
  3. Childers NK, Denys FR, McGee NF, Michalek SM. Ultrastructural study of liposome uptake by M cell of rat Peyer's patch: an oral vaccine system for delivery of purified antigen. Reg Immunol. 1990. 3: 289-296.
  4. Demarger-Andre S, Domard A. Chitosan behaviours in a dispersion of undecylenic acid. Carbohyd Polym. 1993. 22: 117-126. https://doi.org/10.1016/0144-8617(93)90074-E
  5. Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm. 1999. 182: 21-32. https://doi.org/10.1016/S0378-5173(99)00030-7
  6. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunol Today 1990. 11: 89-96. https://doi.org/10.1016/0167-5699(90)90034-7
  7. Guo J, Ping Q, Jiang G, Huang L, Tong Y. Chitosan-coated liposomes: characterization and interaction with leuprolide. Int J Pharm. 2003. 260: 167-173. https://doi.org/10.1016/S0378-5173(03)00254-0
  8. Han M, Watarai S, Kobayashi K, Yasuda T. Application of liposomes for development of oral vaccines: Study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization. J Vet Med Sci. 1997. 59: 1109-1114. https://doi.org/10.1292/jvms.59.1109
  9. Henriksen I, Vågen SR, Snade SA, Smistad G, Karlsen J. Interaction between liposomes and chitosan II: effect of selected parameters on aggregation and leakage. Int J Pharm. 1997. 146: 193-204. https://doi.org/10.1016/S0378-5173(96)04801-6
  10. He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 1998. 166: 75-88. https://doi.org/10.1016/S0378-5173(98)00027-1
  11. He S, Zhu J, Xie F. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release. Pharmazie. 2010. 65: 467-470.
  12. Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev. 2001. 51: 81-96. https://doi.org/10.1016/S0169-409X(01)00171-5
  13. Kokkona M, Kallinteri P, Fatiuros D, Antimisiaris SG. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipase: effect of lipid composition. Eur J Pharm Sci. 2000. 9: 245-252. https://doi.org/10.1016/S0928-0987(99)00064-0
  14. Larrabee A. Time-dependent changes in the size distribution of disteroylphos-phatidylcholine vesicles. Biochemistry. 1979. 18: 3321. https://doi.org/10.1021/bi00582a019
  15. Lee CM, Lee HC, Lee KY. O-palmitoylcurdlan sulfate (OPCurS)- coated liposomes for oral drug delivery. J Biosci Bioeng. 2005. 100: 255-259. https://doi.org/10.1263/jbb.100.255
  16. Manconi M, Mura S, Manca ML, Fadda AM, Dolz M, Hernandez MJ, Casanovas A, Díez-Sales O. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization. Int J Pharm. 2010. 392: 92-100. https://doi.org/10.1016/j.ijpharm.2010.03.038
  17. Minato S, Iwanaga K, Kakemi M, Yamashita S, Oku N. Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity. J Control Release. 2003. 89: 189-197. https://doi.org/10.1016/S0168-3659(03)00093-2
  18. Miyazaki Y, Ogihara K, Yakou S, Nagai T, Takayama K. In vitro and vivo evaluation of mucoadhesive microspheres consisting of dextran derivatives and cellulose acetate butyrate. Int J Pharm. 2003. 258: 21-29. https://doi.org/10.1016/S0378-5173(03)00159-5
  19. Moreia JN, Almeida LM, Geraldes CF, Costa ML. Evaluation of in vitro stability of large unilamellar liposomes coated with a modified polysaccharide (O-palmitoylpullulan). J Mater Sci:Mater Med. 1996. 7: 301-303. https://doi.org/10.1007/BF00058571
  20. Parmentier J, Becker MM, Heintz U, Fricker G. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids. Int J Pharm. 2011. 405: 210 -217. https://doi.org/10.1016/j.ijpharm.2010.12.005
  21. Porta R, Mariniello L, Di Pierro P, Sorrentino A, Giosafatto CV. Transglutaminase crosslinked pectin- and chitosan-based edible films: a review. Crit Rev Food Sci Nutr. 2011. 51: 223 -238. https://doi.org/10.1080/10408390903548891
  22. Prestegard JH, Fellmeth B. Fusion of dimyristoyllecithins vesicles as studied by proton magnetic resonance spectroscopy. Biochemistry. 1974. 13: 1122. https://doi.org/10.1021/bi00703a011
  23. Regen SL, Czech B, Singh A. Polymerized vesicles. J Am Chem Soc. 1980. 102: 6638. https://doi.org/10.1021/ja00541a078
  24. Sihorkar V, Vyas SP. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. J Pharm Pharmaceut Sci. 2001. 4: 138-158.
  25. Takeuchi H, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm. 2005. 303: 160-170. https://doi.org/10.1016/j.ijpharm.2005.06.028
  26. Takeuchi H, Yamamoto H, Niwa T, Hino T, Kawashima Y. Mucoadhesion of polymer-coated liposomes to rat intestine in vitro. Chem Pharm Bull. 1994. 42: 1954-1956. https://doi.org/10.1248/cpb.42.1954
  27. Venkatesan N, Vyas SP. Polysaccharide coated liposomes for oral immunization-development and characterization. Int J Pharm. 2000. 203: 169-177. https://doi.org/10.1016/S0378-5173(00)00442-7
  28. Zhou F, Neutra MR. Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier. Biosci Rep. 2002. 22: 355-369. https://doi.org/10.1023/A:1020103109483
  29. Zhu J, Yan F, Guo Z, Marchant RE. Surface modification of liposomes by saccharides: Vesicle size and stability of lactosyl liposomes studied by photon correlation spectroscopy. J Colloid Interf Sci. 2005. 289: 542-550. https://doi.org/10.1016/j.jcis.2005.03.088
  30. Zhuang J, Ping Q, Song Y, Qi J, Cui Z. Effects of chitosan coating on physical properties and pharmacokinetic behavior of mitoxantrone liposomes. Int J Nanomedicine. 2010. 5: 407 -416.